Improving Patient Compliance with Long-Term Oxygen Therapy in COPD
Author Information
Author(s): Stamatis Katsenos, Stavros H. Constantopoulos
Primary Institution: University Hospital of Ioannina
Hypothesis
What factors affect patient compliance with long-term oxygen therapy in COPD?
Conclusion
Suboptimal adherence to long-term oxygen therapy is common and leads to significant morbidity and healthcare costs.
Supporting Evidence
- Long-term oxygen therapy improves survival in hypoxemic COPD patients when used for more than 15 hours a day.
- Adherence to long-term oxygen therapy ranges from 45% to 70%.
- Patients often do not perceive the clinical benefits of continuous oxygen use.
Takeaway
Many people with COPD don't use their oxygen therapy as much as they should, which can make them sicker and cost a lot of money.
Methodology
This review article summarizes existing literature on factors influencing compliance and strategies to improve adherence to long-term oxygen therapy.
Potential Biases
Potential biases may arise from the reliance on self-reported adherence and the subjective nature of patient experiences.
Limitations
The review primarily discusses descriptive studies and lacks behavioral or psychological approaches.
Participant Demographics
The study involved COPD patients, with a significant portion being elderly and some active smokers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website